Remove Drug Development Remove Marketing Remove Trials
article thumbnail

Considering the use of animal models in drug development

Drug Discovery World

Animal models (AMs) have generally been seen as useful for drug development and biomedical research for many years. Drugs developed in animals often fail in human studies. Are AMs always necessary and unavoidable? Possibly not.

article thumbnail

Free clinical trial health check to bring drugs to market faster

Drug Discovery World

A new free service will offer insights in under ten days to sponsors conducting clinical trials, identifying potential ‘zombie trials’ and providing actionable recommendations for failing trials. The Health Check and Trial Rescue Service is an initiative of data software and services company Phesi.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Three trends in the antibody-drug conjugate (ADC) market 

Drug Discovery World

According to NCBI, most of the ADCs developed so far are for use in the treatment of cancer, but there is plenty of potential for using ADCs to treat other diseases 1. A Nature publication confirmed that there are currently 12 FDA-approved ADCs on the market, and nine of these secured FDA approval in the past six years 2.

Marketing 245
article thumbnail

The Collaboration Between Industry and Academia in Drug Development

DrugBank

Drug development is challenging, including not only the complexities of biomolecular drug mechanisms but also the convolutions of regulatory pathways and commercialization strategies. This includes funding large-scale clinical trials and establishing robust manufacturing/distribution networks.

article thumbnail

DDW Cancer Research Summit: Strategies to get to market faster

Drug Discovery World

Andreas Dreps DDW is delighted to confirm that ICON’s SrVP and Global Head of Science Andreas Dreps and Senior Director Muaiad Kittaneh will present a session on identifying research strategies to get to market faster. The post DDW Cancer Research Summit: Strategies to get to market faster appeared first on Drug Discovery World (DDW).

Marketing 130
article thumbnail

Could NfL accelerate drug development for neurodegenerative diseases?

Drug Discovery World

Professor Andy Whiting and Dr Tony Lockett discuss how specific levels of a protein could be used to advance drug development in neurodegenerative diseases. They can predict which drugs might clinically benefit patients in personalised medicine, thereby reducing the length and size of trials needed to screen for effective medication.

article thumbnail

Post-COVID-19 cognitive impairment: a new target for drug development?

Drug Discovery World

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. These may provide an opportunity for treatment for post-Covid-19 cognitive impairment.